2010
DOI: 10.1016/j.poly.2009.06.075
|View full text |Cite
|
Sign up to set email alerts
|

The next generation of C2-symmetric ligands: A di-N-heterocyclic carbene (NHC) ligand and the synthesis and X-ray characterization of mono- and dinuclear rhodium(I) and iridium(I) complexes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

1
8
0

Year Published

2010
2010
2022
2022

Publication Types

Select...
4
2
1

Relationship

2
5

Authors

Journals

citations
Cited by 20 publications
(9 citation statements)
references
References 41 publications
1
8
0
Order By: Relevance
“…In particular, four isopropyl methyl resonances appear at 22.5, 23.6, 23.9, and 25.4 ppm and the corresponding methines resonate at 54.9 and 52.1 ppm. The carbene carbons resonate as doublets (J ¼ 53 Hz) at 178.0 and 177.8 ppm, consistent with other rhodium imidazole-NHCs[14,66,67]. The COD olefinic carbons also resonate as doublets at 92.4, 88.6, 87.5, and 85.4 ppm with coupling constants that range between 5 and 9 Hz.…”
supporting
confidence: 77%
See 2 more Smart Citations
“…In particular, four isopropyl methyl resonances appear at 22.5, 23.6, 23.9, and 25.4 ppm and the corresponding methines resonate at 54.9 and 52.1 ppm. The carbene carbons resonate as doublets (J ¼ 53 Hz) at 178.0 and 177.8 ppm, consistent with other rhodium imidazole-NHCs[14,66,67]. The COD olefinic carbons also resonate as doublets at 92.4, 88.6, 87.5, and 85.4 ppm with coupling constants that range between 5 and 9 Hz.…”
supporting
confidence: 77%
“…Scheme 1 is a generic synthetic methodology for the preparation of C 2 -symmetric DEAM diazolium triflate salts [17,18,65,66]. The synthesis of the diazolium salts (S,S)-trans-1,1 0 -(9,10-dihydro-9,10-ethanoanthracene-11,12-diyldimethanediyl)bis(3-(2-methylphenyl-1-benzyl)-1H-benzimidazol-3-ium)bis(triflouromethansulfonate) [DEAM-o-MBBI][OTf] 2 (3) and (S,S,R,R)-trans-1,1 0 -(9,10-dihydro-9,10-ethanoanthracene-11,12-diyldimethanediyl)bis(3-(R-1-phenylethane)-1H-imidazol-3-ium) [DEAM-PEI][OTf] 2 (4) involves treating two equivalents of 1-benzyl(2-methylphenyl)-benzimidazole (1) or R-1-(1-phenylethyl)-1H-imidazole (2) [75] with an equivalent of (S,S)-trans-9,10-dihydro-9,10-ethanoanthracene-11,12-diyldimethanediyl bis(trifluoromethanesulfonate) [76] in refluxing DME.…”
Section: Synthesis Of Diimidazolium and Dibenzimidazolium Ligand Precmentioning
confidence: 99%
See 1 more Smart Citation
“…[9][10][11][12][13][14][15][16][17][18] An example of such a "hybrid" system is Burgess and co-workers' oxazoline-functionalized NHC iridium hydrogenation catalyst, [19] which hydrogenates unfunctionalized olefins under 1 bar of H 2 with excellent enantioselectivities. [9][10][11][12][13][14][15][16][17][18] An example of such a "hybrid" system is Burgess and co-workers' oxazoline-functionalized NHC iridium hydrogenation catalyst, [19] which hydrogenates unfunctionalized olefins under 1 bar of H 2 with excellent enantioselectivities.…”
Section: Introductionmentioning
confidence: 99%
“…33 Furthermore, the bis-NHC-Au I complexes were more active than the corresponding mono-NHC-Au I complexes. 28 This last discovery prompted us to apply our unique chiral diNHC ligand trans-9,10-D̲ ihydro-9,10-E̲ thanoA̲ nthracene-11,12-diylM̲ ethanediyl [34][35][36][37][38][39][40] (DEAM) to create new Au I complexes for application as anti-cancer agents. Another motivating factor was that no chiral NHC-Au I complexes had been tested; therefore, we sought to determine if cell-selectivity could be improved by employing chiral chrysotherapy.…”
Section: Introductionmentioning
confidence: 99%